Lead author, publication date | Name of study or source of participants | Baseline population | Study design | Location | Baseline year of study | Age group (years) | Males(%) | PCI (n) | CABG(n) | Primary outcome | Follow-up time for endpoints |
Buszman, 2008; 9 Buszman, 201620 | LE MANS | Patients with >50% narrowing of ULMCA, with or without multivessel CAD suitable for equal revascularisation both with PCI and CABG, and were symptomatic with documented myocardial ischaemia | Prospective multicentre RCT | Poland | 2008 | 61.0* | 66.7 | 52 | 53 | Major adverse cardiac and cerebral events | 30 days, 1 year and 10 years |
Morice, 2010; Kappetein, 2011; Morice, 201416–18 | SYNTAX | Patients with de novo LM and/or 3-VD disease and ≥50 target vessel stenosis with stable or unstable angina | Prospective multicentre RCT | USA and Europe | 2005 to 2007 | 65.5* | 73.8 | 357 | 348 | Major adverse cardiac and cerebral events | 1, 3 and 5 years |
Boudriot, 20118 | NS | Patients with stenosis (≥50%) of the ULM with or without additional CAD | Prospective multicentre RCT | Germany | 2003 to 2009 | 18–80 | 74.6 | 100 | 101 | Major adverse cardiac events | 30 days and 1 year |
Park, 2011; 10 Ahn, 201519 | PRECOMBAT | Patients with a diagnosis of stable angina, unstable angina, silent ischaemia or non-ST segment elevation MI | Prospective open-label multicentre RCT | South Korea | 2004 to 2009 | >18 | 76.5 | 300 | 300 | Major adverse cardiac or cerebral events | 30 days, 1 year and 5 years |
Stone, 20166 | EXCEL | Patients with ULMCA with angiographic diameter stenosis ≥70% | Open-label multicentre RCT | 17 countries | 2010 to 2014 | 65.9* | 76.9 | 948 | 957 | Composite of death from any cause, stroke or MI | 30 days and 3 years |
Makikallio, 201634 | NOBLE | Patients with stable angina pectoris, unstable angina pectoris or acute coronary syndrome, together with a lesion with visually assessed stenosis diameter ≥50% or fractional flow reserve ≤0.80 in the LMCA ostium, mid-shaft or bifurcation, with no more than three additional non-complex lesions | Open-label non-inferiority multicentre RCT | 36 centres in Europe | 2008 to 2015 | 66.2* | 78.4 | 592 | 592 | Major adverse cardiac or cerebral events | 30 days, 1 year and 5 years |
*Mean age.
CABG, coronary artery bypass grafting; CAD, coronary artery disease; EXCEL, Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization; NOBLE, Nordic-Baltic-British left main revascularisation study; MI, myocardial infarction; NS, not stated; PCI, percutaneous coronary intervention; RCT, randomised controlled trial; SYNTAX, The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery; ULMCA, unprotected left main coronary artery; 3-VD, 3-vessel disease.